Amoy Diagnostics Co Ltd Class A 300685
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 21.10
- Day Range
- CNY 20.94–21.55
- 52-Week Range
- CNY 14.60–28.46
- Bid/Ask
- CNY 21.54 / CNY 21.55
- Market Cap
- CNY 8.59 Bil
- Volume/Avg
- 4.8 Mil / 5.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 44.96
- Price/Sales
- 8.83
- Dividend Yield (Trailing)
- 0.66%
- Dividend Yield (Forward)
- 0.66%
- Total Yield
- 0.65%
Company Profile
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,119
- Website
- http://www.amoydx.com
Comparables
Valuation
|
Metric
|
300685
|
002030
|
300289
|
|---|---|---|---|
Price/Earnings (Normalized) | 44.96 | 14.66 | 207.50 |
Price/Book Value | 5.34 | 1.17 | 1.30 |
Price/Sales | 8.83 | 8.80 | 4.60 |
Price/Cash Flow | 31.26 | 22.59 | 17.49 |
Price/Earnings
300685
002030
300289
Financial Strength
|
Metric
|
300685
|
002030
|
300289
|
|---|---|---|---|
Quick Ratio | 13.42 | — | — |
Current Ratio | 13.97 | — | — |
Interest Coverage | 194.63 | — | — |
Quick Ratio
300685
002030
300289
Profitability
|
Metric
|
300685
|
002030
|
300289
|
|---|---|---|---|
Return on Assets (Normalized) | 11.25% | — | — |
Return on Equity (Normalized) | 12.34% | — | — |
Return on Invested Capital (Normalized) | 12.20% | — | — |
Return on Assets
300685
002030
300289
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Cjgyrbnhq | Xvsjb | $209.3 Bil | |
DHR
| Danaher Corp | Ccmgvhbxy | Qgdyk | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Rmgrmmr | Twmnhp | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Ywxcyzhll | Bswltg | $41.0 Bil | |
A
| Agilent Technologies Inc | Jxfxgbzp | Dfjrm | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Pbgjymkjx | Nwglm | $26.4 Bil | |
ICLR
| Icon PLC | Znjgfrwl | Dtqzbd | $24.8 Bil | |
ILMN
| Illumina Inc | Fmxzswfh | Gzpwzp | $19.3 Bil | |
WAT
| Waters Corp | Gxshxlkxl | Mgb | $18.3 Bil | |
LH
| Laboratory Corp of America Holdings | Pjqfbzww | Dllbsb | $17.5 Bil |